Fertilizers & Agrochemicals
Valuation | |
|---|---|
| Market Cap | 5.31 kCr |
| Price/Earnings (Trailing) | 31.95 |
| Price/Sales (Trailing) | 1.82 |
| EV/EBITDA | 15.04 |
| Price/Free Cashflow | 24.41 |
| MarketCap/EBT | 23.4 |
| Enterprise Value | 5.35 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | -0.20% |
| Price Change 1M | 1.4% |
| Price Change 6M | -23.6% |
| Price Change 1Y | 12.2% |
| 3Y Cumulative Return | 9.9% |
| 5Y Cumulative Return | 0.10% |
| 7Y Cumulative Return | 7.7% |
| 10Y Cumulative Return | 5.2% |
| Revenue (TTM) |
| 2.91 kCr |
| Rev. Growth (Yr) | 19.7% |
| Earnings (TTM) | 167 Cr |
| Earnings Growth (Yr) | -81.8% |
Profitability | |
|---|---|
| Operating Margin | 9% |
| EBT Margin | 8% |
| Return on Equity | 8.14% |
| Return on Assets | 5.02% |
| Free Cashflow Yield | 4.1% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -214 Cr |
| Cash Flow from Operations (TTM) | 295 Cr |
| Cash Flow from Financing (TTM) | -80 Cr |
| Cash & Equivalents | 20 Cr |
| Free Cash Flow (TTM) | 227 Cr |
| Free Cash Flow/Share (TTM) | 11.67 |
Balance Sheet | |
|---|---|
| Total Assets | 3.33 kCr |
| Total Liabilities | 1.28 kCr |
| Shareholder Equity | 2.05 kCr |
| Current Assets | 2.26 kCr |
| Current Liabilities | 1.18 kCr |
| Net PPE | 657 Cr |
| Inventory | 770 Cr |
| Goodwill | 196 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.02 |
| Debt/Equity | 0.03 |
| Interest Coverage | 19.64 |
| Interest/Cashflow Ops | 27.82 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 2.5 |
| Dividend Yield | 0.94% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Balance Sheet: Strong Balance Sheet.
Size: Market Cap wise it is among the top 20% companies of india.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: In past three years, the stock has provided 9.9% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money is losing interest in the stock.
Momentum: Stock has a weak negative price momentum.
Balance Sheet: Strong Balance Sheet.
Size: Market Cap wise it is among the top 20% companies of india.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Past Returns: In past three years, the stock has provided 9.9% return compared to 12.8% by NIFTY 50.
Smart Money: Smart money is losing interest in the stock.
Momentum: Stock has a weak negative price momentum.
Investor Care | |
|---|---|
| Dividend Yield | 0.94% |
| Dividend/Share (TTM) | 2.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 8.55 |
Financial Health | |
|---|---|
| Current Ratio | 1.91 |
| Debt/Equity | 0.03 |
Technical Indicators | |
|---|---|
| RSI (14d) | 63.6 |
| RSI (5d) | 48.43 |
| RSI (21d) | 50.29 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Sell |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Summary of Rallis India's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management provided an optimistic outlook for Rallis India Limited, navigating through a challenging agrochemical market landscape characterized by weak demand drivers, particularly due to low crop prices and weather issues. For FY26, the management expects industry growth of 3-4%, positioning the market size at approximately USD 9.6-10.0 billion. They anticipate Rabi acreage to increase by 3% year-on-year, supporting better sell-out in Q4.
In terms of financial performance, Q3FY26 revenue rose to Rs.623 crore, an increase of 19% from Rs.522 crore in Q3FY25. However, the profit after tax dropped to Rs.2 crore from Rs.11 crore the previous year due to a Rs.40 crore exceptional item related to gratuity provisions. EBITDA grew by 29% to Rs.58 crore. Crop Care segment revenue grew by 18% to Rs.580 crore, while Seeds revenue surged 46% to Rs.43 crore.
Management emphasized several key forward-looking strategies, including:
The overall sentiment remains cautiously optimistic, with management committing to disciplined capital efficiency and a cautious approach to inventory management amidst fluctuating demand dynamics.
Understand Rallis India ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Tata Chemicals Limited | 55.04% |
| SBI MUTUAL FUND (Various Funds) | 9.43% |
| Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc | 1.87% |
| Robeco Capital Growth Funds | 1.17% |
| National Insurance Company Ltd | 1.1% |
| Tata Chemicals International Pte. Ltd | 0% |
Detailed comparison of Rallis India against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| UPL | UPL | 63.13 kCr | 49.67 kCr | -6.50% | +15.80% | 35.81 | 1.27 | - | - |
| PIIND | PI Industries | 47.67 kCr | 7.78 kCr |
Comprehensive comparison against sector averages
RALLIS metrics compared to Fertilizers
| Category | RALLIS | Fertilizers |
|---|---|---|
| PE | 32.12 | 30.36 |
| PS | 1.83 | 2.14 |
| Growth | 8 % | 9.3 % |
Rallis India Limited manufactures and markets agri-input in India and internationally. The company offers crop protection products, including insecticides, herbicides, fungicides, and bio pesticide; organic fertilizers and plant growth nutrients; seeds, such as maize, watermelon, cauliflower, cabbage, bottle gourd, cucumber, bitter gourd, chilli, okra, tomato, millet, paddy, and cotton; and animal nutrition products. It also provides household products, such as Termex, an insecticide for termite control; Sentry, a chemical composition pest control; and Ralligel plus, a chemical spray for cockroach control. In addition, the company offers contract manufacturing services for crop protection chemicals, specialty chemicals, polymers, and intermediates. It sells its products through a network of dealers and retailers. The company was incorporated in 1948 and is based in Mumbai, India. Rallis India Limited operates as a subsidiary of Tata Chemicals Limited.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
RALLIS vs Fertilizers (2021 - 2026)
Viraj: "Can you give the volume price trend for the quarter in domestic, B2C, and international business? Also, any color on inventory liquidation and the industry?"
Gyanendra Shukla: "Volume in the domestic B2C business saw a positive impact of approximately 25%, offset by a negative price impact of 12%. Export volumes grew by almost 73%, while our seed business saw a 46% increase. We're managing inventory carefully and expect to liquidate what's in the market through January to March."
Arjun Khanna: "What is your outlook on the impact of the discontinuation of the Chinese VAT rebate on technical exports?"
Gyanendra Shukla: "While the VAT rebate discontinuation is set for April, we don't expect immediate adverse effects, especially since we primarily deal in acephate and similar products. However, it could lead to price increases if production does not meet market demands."
Siddharth Gadekar: "Can you comment on the gross margins for your technical business and future efficiency improvements?"
Gyanendra Shukla: "Our export margins exceed 20%, while the CSM blended margins are around 30%. We're exploring various strategies to improve realizations and enhance profitability in our operations, including domestic sales and optimizing output efficiency."
Saurabh Jain: "Given your aspiration to expand margins by 500 bps, how do you see margins evolving in the near term?"
Gyanendra Shukla: "We're focusing on EBITDA margin improvements rather than on gross margins alone. Key to achieving this will be leveraging operational efficiencies and maintaining competitive market participation. We see operating leverage as a crucial factor going forward."
Ramesh Shankaranarayanan: "What is your capital expenditure plan to support your aspirations for growth in the seed and soil health segments?"
Gyanendra Shukla: "We plan to avoid substantial capex unless firm contracts are in place. Our existing inventory and equipment are sufficient for growth. However, ongoing small-scale capex is necessary to maintain operational readiness and meet demand."
| Homefield Pvt. UK Limited | 0% |
| TC Africa Holdings Limited | 0% |
| Tata Chemicals South Africa Proprietary Limited | 0% |
| Tata Chemicals Magadi Limited | 0% |
| Magadi Railway Company Limited | 0% |
| TCE Group Limited | 0% |
| Natrium Holdings Limited | 0% |
| Cheshire Salt Holdings Limited | 0% |
| Cheshire Salt Limited | 0% |
| British Salt Limited | 0% |
| New Cheshire Salt Works Limited | 0% |
| Brunner Mond Group Limited | 0% |
| Tata Chemicals Europe Limited | 0% |
| Winnington CHP Limited | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
| -12.60% |
| 31.52 |
| 6.13 |
| - |
| - |
| SUMICHEM | SUMITOMO CHEMICAL INDIA | 20.96 kCr | 3.38 kCr | -11.30% | -19.80% | 39.44 | 6.2 | - | - |
| BAYERCROP | Bayer CropScience | 19.83 kCr | 6.24 kCr | -1.10% | -11.50% | 24.17 | 3.18 | - | - |
| DHANUKA | Dhanuka Agritech | 6.34 kCr | 2.01 kCr | -5.70% | -24.50% | 21.45 | 3.06 | - | - |
| 5% |
| 275 |
| 262 |
| 256 |
| 239 |
| 216 |
| 199 |
| Finance costs | -35.3% | 12 | 18 | 12 | 4.79 | 5.21 | 6.11 |
| Depreciation and Amortization | 5.3% | 120 | 114 | 91 | 74 | 64 | 62 |
| Other expenses | 4.6% | 521 | 498 | 550 | 467 | 415 | 402 |
| Total Expenses | 1.6% | 2,509 | 2,469 | 2,852 | 2,409 | 2,176 | 2,058 |
| Profit Before exceptional items and Tax | -4.6% | 186 | 195 | 127 | 222 | 294 | 228 |
| Exceptional items before tax | - | 1 | 1 | 0.62 | 0 | 9.45 | 11 |
| Total profit before tax | -4.6% | 187 | 196 | 128 | 222 | 304 | 239 |
| Current tax | -6.8% | 56 | 60 | 45 | 62 | 77 | 69 |
| Deferred tax | 138.5% | 6 | -12 | -9.07 | -3.97 | -2.1 | -15.27 |
| Total tax | 29.8% | 62 | 48 | 36 | 58 | 75 | 54 |
| Total profit (loss) for period | -15.6% | 125 | 148 | 92 | 164 | 229 | 185 |
| Other comp. income net of taxes | - | -2 | 0 | -0.2 | -0.65 | 1.32 | -1.84 |
| Total Comprehensive Income | -17% | 123 | 148 | 92 | 164 | 230 | 184 |
| Earnings Per Share, Basic | -17.9% | 6.43 | 7.61 | 4.73 | 8.45 | 11.76 | 9.54 |
| Earnings Per Share, Diluted | -17.9% | 6.43 | 7.61 | 4.73 | 8.45 | 11.76 | 9.54 |
| - |
| 1 |
| 1 |
| 1 |
| 1 |
| 0 |
| 0.12 |
| Goodwill | 0% | 196 | 196 | 196 | 196 | 196 | 196 |
| Non-current investments | 0% | 4 | 4 | 4 | 4 | 4 | 3.18 |
| Loans, non-current | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total non-current financial assets | -10.5% | 18 | 20 | 20 | 20 | 17 | 23 |
| Total non-current assets | -3.7% | 1,068 | 1,109 | 1,130 | 1,223 | 1,250 | 1,153 |
| Total assets | 11.9% | 3,328 | 2,974 | 3,109 | 3,003 | 3,062 | 2,798 |
| Borrowings, non-current | -2% | 50 | 51 | 55 | 113 | 116 | 24 |
| Total non-current financial liabilities | -2% | 50 | 51 | 55 | 113 | 116 | 24 |
| Provisions, non-current | 2.3% | 45 | 44 | 44 | 41 | 41 | 42 |
| Total non-current liabilities | -5.9% | 96 | 102 | 100 | 156 | 163 | 79 |
| Borrowings, current | -9.1% | 11 | 12 | 13 | 20 | 13 | 113 |
| Total current financial liabilities | 43.2% | 1,039 | 726 | 974 | 820 | 962 | 858 |
| Provisions, current | -18.2% | 10 | 12 | 11 | 11 | 9 | 7.43 |
| Current tax liabilities | 2200% | 47 | 3 | 33 | 2 | 31 | 3.26 |
| Total current liabilities | 21.9% | 1,180 | 968 | 1,085 | 1,018 | 1,073 | 989 |
| Total liabilities | 19.3% | 1,276 | 1,070 | 1,185 | 1,174 | 1,236 | 1,068 |
| Equity share capital | 0% | 19 | 19 | 19 | 19 | 19 | 19 |
| Total equity | 7.8% | 2,052 | 1,904 | 1,924 | 1,829 | 1,826 | 1,730 |
| Total equity and liabilities | 11.9% | 3,328 | 2,974 | 3,109 | 3,003 | 3,062 | 2,798 |
| 6.4% |
| 350 |
| 329 |
| 266 |
| 234 |
| - |
| - |
| Income taxes paid (refund) | -8.5% | 55 | 60 | 49 | 68 | - | - |
| Net Cashflows From Operating Activities | 9.7% | 295 | 269 | 217 | 166 | - | - |
| Proceeds from sales of PPE | 100% | 3 | 2 | 1.9 | 4.45 | - | - |
| Purchase of property, plant and equipment | -2.9% | 68 | 70 | 169 | 156 | - | - |
| Purchase of intangible assets | -54.5% | 6 | 12 | 18 | 29 | - | - |
| Dividends received | - | 0 | 0 | 0.07 | 0.05 | - | - |
| Interest received | - | 1 | 0 | 3.75 | 3.2 | - | - |
| Other inflows (outflows) of cash | 50% | 0 | -1 | 48 | -9.52 | - | - |
| Net Cashflows From Investing Activities | -108.7% | -214 | -102 | -142.1 | -102.93 | - | - |
| Proceeds from borrowings | 100% | 13 | 7 | 386 | 25 | - | - |
| Repayments of borrowings | -88.8% | 13 | 108 | 340 | 8.44 | - | - |
| Payments of lease liabilities | -4.2% | 24 | 25 | 19 | 17 | - | - |
| Dividends paid | 0% | 49 | 49 | 58 | 59 | - | - |
| Interest paid | -25% | 7 | 9 | 9.42 | 1.85 | - | - |
| Other inflows (outflows) of cash | - | 0 | 0 | 0.07 | 0.17 | - | - |
| Net Cashflows from Financing Activities | 56.2% | -80 | -184 | -41.05 | -61.44 | - | - |
| Net change in cash and cash eq. | 100% | 1 | -17 | 34 | 1.49 | - | - |